| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.anglifesciences.com | |
| Market Cap | 74.69 Cr. | |
| Enterprise Value(EV) | 136.13 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -8.50 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 41.99 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 61.15 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 0.94 | Calculated using Price: 57.20 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 1.31 Cr. | 13,058,287 Shares |
| FaceValue | 10 | |
| About ANG Lifesciences India Ltd. | ||
| The company is ISO-9001:2008 certified and has the modern & sophisticated plant, equipments, technique and manpower. The planning and construction of plant has been done to conform to the regulatory requirements as per the norms of WHO G.M.P. and G.L.P. as per schedule-M (revised). They manufacture their products in compliance with GMP requirements. They have dedicated area, machinery, facilities and advanced equipments for manufacturing of B-Lactum & Non-B Lactum products as per GMP Norms. The production block provides appropriate personnel and material flow. As per GMP norms, all the production processes are documented and validated to establish the accuracy of the procedures and the control measures. The Company's production capacity is 700 Lakhs Pcs per annum on per shift basis. Their products include sterile dry powder vials for Anti Biotics, Anti Ulcerant, Gluco corticoid and Anti inflammatory, Anti malarial and Anesthetic. | ||
| 1 Day |
|
-0.85% |
| 1 Week |
|
+0.28% |
| 1 Month |
|
+9.68% |
| 3 Month |
|
-21.07% |
| 6 Month |
|
-15.63% |
| 1 Year |
|
-34.61% |
| 2 Year |
|
-73.30% |
| 5 Year |
|
+148.25% |
| 10 Year |
|
| 2 years | 2022-03 | 2023-03 | |
| Return on Equity (%) | 48.13 | -0.31 | |
| Return on Capital Employed (%) | 39.14 | 9.53 | |
| Return on Assets (%) | 14.06 | -0.09 |
| Particulars | 3 years | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 84 | 86 | 86 | |
| Non Curr. Liab. | 37 | 27 | 23 | |
| Curr. Liab. | 166 | 162 | 156 | |
| Minority Int. | ||||
| Equity & Liab. | 287 | 276 | 265 | |
| Non Curr. Assets | 94 | 89 | 86 | |
| Curr. Assets | 193 | 185 | 179 | |
| Misc. Exp. not W/O | ||||
| Total Assets | 287 | 276 | 265 |
| Particulars | 3 years | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 354 | 220 | 148 | |
| Other Income | 1 | 10 | 10 | |
| Total Income | 355 | 230 | 157 | |
| Total Expenditure | -286 | -205 | -152 | |
| PBIDT | 69 | 24 | 6 | |
| Interest | -9 | -12 | -9 | |
| Depreciation | -6 | -9 | -9 | |
| Taxation | -13 | -3 | 1 | |
| Exceptional Items | ||||
| PAT | 40 | 0 | -11 | |
| Minority Interest | ||||
| Share Associate | ||||
| Other Related Items | 1 | |||
| Consolidated Net Profit | 40 | 0 | -11 | |
| Adjusted EPS | 31 | 0 | -9 |
| Particulars | 2 years | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 25 | 26 | |
| Cash Fr. Inv. | -44 | -9 | |
| Cash Fr. Finan. | 20 | -17 | |
| Net Change | 0 | 0 | |
| Cash & Cash Eqvt | 0 | 0 |
|
Sat, 20 Apr 2024
Compliance Certificate For The Year Ended 31.03.2024 Please find & enclosed herewith Compliance certificate under Reg 7(3) ofSEBI LODR 2015 for the year ended 31.03.2024 |
|
Sat, 20 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Please find & enclosed herewith certificate dated 15.04.2024 issued by Bigshare Services Pvt Ltd (RTA) for the quarter ended as at 31.03.2024 |
|
Wed, 10 Apr 2024
Clarification On Price Movement Sir/Madam We hereby submit the clarification about Share price movement. |
| Fri, 26 Apr 2024 |
Higher Delivery Quantity
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
High Increase in 1 Month
|
High Decrease in 3 Months
|
